 Connection
Jacob Painter to Buprenorphine
This is a "connection" page, showing publications Jacob Painter has written about Buprenorphine.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.214 |
|
|
|
-
Cetto AV, Chandler MW, Shah NK, Luciani LL, Painter J. Evaluating the Impact of Buprenorphine on Depressive Symptoms Among Veterans with Chronic Pain. J Pain Palliat Care Pharmacother. 2025 Mar; 39(1):58-63.
Score: 0.820
-
Becker WC, Seal KH, Nelson DB, DeRonne BM, Kats AM, Morasco BJ, Frank JW, Makris UE, Painter JT, Allen KD, Mixon AS, Bohnert A, Reznik TE, Hagedorn HJ, Hammett P, Borsari B, Baxley C, Krebs EE. Buprenorphine, Pain, and Opioid Use in Patients Taking High-Dose Long-Term Opioids: A Randomized Clinical Trial. JAMA Intern Med. 2025 Apr 01; 185(4):372-381.
Score: 0.210
-
Shah NK, Chandler MW, Cetto AV, Luciani LL, Painter J, Bailey D. Retrospective Cohort Study of Safety Outcomes Associated with Opioid Rotations to Buprenorphine. J Pain Palliat Care Pharmacother. 2023 Sep; 37(3):234-245.
Score: 0.184
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|